Sanofi launches $15bn loan for Genzyme bid
France’s Sanofi-Aventis launched a $15bn loan into syndication this week after initiating an $18.5bn hostile bid for US biotech firm Genzyme on Monday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
